1. Home
  2. CVKD vs OPTT Comparison

CVKD vs OPTT Comparison

Compare CVKD & OPTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • OPTT
  • Stock Information
  • Founded
  • CVKD 2022
  • OPTT 1984
  • Country
  • CVKD United States
  • OPTT United States
  • Employees
  • CVKD N/A
  • OPTT N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • OPTT Electric Utilities: Central
  • Sector
  • CVKD Health Care
  • OPTT Utilities
  • Exchange
  • CVKD Nasdaq
  • OPTT Nasdaq
  • Market Cap
  • CVKD 8.2M
  • OPTT 8.8M
  • IPO Year
  • CVKD 2023
  • OPTT 2007
  • Fundamental
  • Price
  • CVKD $0.43
  • OPTT $0.36
  • Analyst Decision
  • CVKD Strong Buy
  • OPTT
  • Analyst Count
  • CVKD 2
  • OPTT 0
  • Target Price
  • CVKD $3.50
  • OPTT N/A
  • AVG Volume (30 Days)
  • CVKD 71.6K
  • OPTT 85.8M
  • Earning Date
  • CVKD 08-12-2024
  • OPTT 09-11-2024
  • Dividend Yield
  • CVKD N/A
  • OPTT N/A
  • EPS Growth
  • CVKD N/A
  • OPTT N/A
  • EPS
  • CVKD N/A
  • OPTT N/A
  • Revenue
  • CVKD N/A
  • OPTT $4,933,000.00
  • Revenue This Year
  • CVKD N/A
  • OPTT N/A
  • Revenue Next Year
  • CVKD N/A
  • OPTT N/A
  • P/E Ratio
  • CVKD N/A
  • OPTT N/A
  • Revenue Growth
  • CVKD N/A
  • OPTT 96.77
  • 52 Week Low
  • CVKD $0.36
  • OPTT $0.12
  • 52 Week High
  • CVKD $2.17
  • OPTT $0.68
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.00
  • OPTT 57.45
  • Support Level
  • CVKD $0.43
  • OPTT $0.37
  • Resistance Level
  • CVKD $0.49
  • OPTT $0.42
  • Average True Range (ATR)
  • CVKD 0.02
  • OPTT 0.08
  • MACD
  • CVKD -0.00
  • OPTT -0.00
  • Stochastic Oscillator
  • CVKD 0.17
  • OPTT 43.61

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

Share on Social Networks: